Thrivous Announces Science Advisor Board
Orem UT – Thrivous, the human enhancement company, announces the formation of its science advisor board. The board will inform ongoing product and service development. Formation of the board reflects Thrivous' commitment to guidance from consensus science in its mission to help customers access technology with the greatest potential to expand human abilities.
"We're excited to establish this relationship with medical and biotech experts," said Lincoln Cannon, CEO at Thrivous. "Their knowledge and experience will complement our work. And that will create more value for our customers. I feel honored to associate with this group."
The science advisor board consists of four members. They include two physicians, a bioscientist, and a neuroscientist. Below are summaries of their qualifications, areas of professional interest, and affiliations.
Cory Funk, PhD
Dr. Cory Funk is a bioscientist with a doctoral degree from the University of Illinois, where he studied the role of estrogens as a master regulator of gene expression in breast cancer. He currently works as a research scientist on brain tumors and Alzheimer’s disease at The Institute for Systems Biology in Seattle.
James Zebrack, MD
Dr. James Zebrack is a physician with a medical degree from the University of Nevada. His professional interests include the study of heart failure, preventative and functional medicine, alternative and natural therapies, and dietary supplements. Dr. Zebrack currently works as a cardiologist at St. Mark’s Hospital in Salt Lake City.
Jordan Roberts, MD
Dr. Jordan Roberts is a physician with a medical degree from the University of Arizona. He has done clinical research on Vitamin D, and his professional interests include preventive care, gerontology, homeless healthcare, and telemedicine. Dr. Roberts currently works in family medicine at St. Mark's Hospital in Salt Lake City.
Michael Ferguson, PhD
Dr. Michael Ferguson is a neuroscientist with a doctoral degree from the University of Utah. His research uses fMRI and psychometric data to predict cognitive ability, and he sees efforts to optimize intelligence as additive to a collective social good. Dr. Ferguson is currently a postdoctoral associate at Cornell University in New York.
Thrivous is the human enhancement company. Its mission is to help people access technology with the greatest potential to improve their brains and bodies. In pursuit of that mission, it develops and distributes nootropics to enhance cognition and geroprotectors to support healthy aging, with open-source formulas and evidence-based dosages of natural ingredients. Its high-value products include Clarity, the daily nootropic to improve focus, memory, and mood, and to support healthy brain function. For more information, please contact email@example.com.